» Articles » PMID: 39717141

BioCart© Opinion-based Study on Home Administration Support for Biological Therapies in Patients with Severe Asthma

References
1.
Gonzalez Barcala F, De La Fuente-Cid R, Alvarez-Gil R, Tafalla M, Nuevo J, Caamano-Isorna F . [Factors associated with asthma control in primary care patients: the CHAS study]. Arch Bronconeumol. 2010; 46(7):358-63. DOI: 10.1016/j.arbres.2010.01.007. View

2.
Plaza V, Alobid I, Alvarez C, Blanco M, Ferreira J, Garcia G . Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies. Arch Bronconeumol. 2021; 58(2):150-158. DOI: 10.1016/j.arbres.2021.05.010. View

3.
Delgado Romero J, Blanco-Aparicio M, Cisneros Serrano C, Diaz-Perez D, Ferrando Piqueres R, Lopez-Carrasco V . Support for Home Administration of Biological Therapy in Patients With Severe Asthma: BioCart©. J Investig Allergol Clin Immunol. 2022; 32(6):482-484. DOI: 10.18176/jiaci.0786. View

4.
Cisneros-Serrano C, Rial M, Gomez-Bastero-Fernandez A, Igea J, Martinez-Meca A, Fernandez-Lison L . Spanish multidisciplinary consensus on the characteristics of severe asthma patients on biologic treatment who are candidates for at-home administration. Rev Clin Esp (Barc). 2022; 223(3):154-164. DOI: 10.1016/j.rceng.2022.11.001. View